BNBX - APPLIED DNA SCIENCES INC


0.7
-0.039   -5.529%

Share volume: 44,175
Last Updated: 03-06-2026
Business Services/Services – Research, Development, Testing Labs: -0.01%

PREVIOUS CLOSE
CHG
CHG%

$0.74
-0.04
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
36%
Profitability 35%
Dept financing 27%
Liquidity 69%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
12.20%
1 Month
-22.48%
3 Months
-77.35%
6 Months
-69.83%
1 Year
403.96%
2 Year
28.68%
Key data
Stock price
$0.70
P/E Ratio 
0.00
DAY RANGE
$0.70 - $0.76
EPS 
-$61.61
52 WEEK RANGE
$0.05 - $7.15
52 WEEK CHANGE
$403.96
MARKET CAP 
5.370 M
YIELD 
N/A
SHARES OUTSTANDING 
5.447 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
03-14-2025
NEXT EARNINGS DATE
05-09-2025
BETA 
5.52
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$81,914
AVERAGE 30 VOLUME 
$83,763
Company detail
CEO: James A. Hayward
Region: US
Website: adnas.com
Employees: 70
IPO year: 2003
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts.

Recent news